Cyteir Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $129M
Investors
- 14
About Cyteir Therapeutics
Based in Massachusetts, US, Cyteir Therapeutics, Inc. was founded in 2012 by co-founders Tim Romberger and Kevin Mills. In 2020, the company advanced its clinical trial to phase 1 for its inhibitor advancing to once-daily dosing. Cyteir filed on the NASDAQ to become a public company in March 2021. Cyteir employs an integrated drug development platform to create a pipeline of small molecule medicines with a variety of possible disease state applications by modulating the imbalance between DNA damage and repair for therapeutic impact. It specializes in treating a variety of hematological cancers, solid tumors, and chronic autoimmune diseases. The company plans to continue to develop its synthetic lethality platform to find new targets that inhibit DNA damage repair, and to continue to evaluate the safety and tolerability of CYT-0851 during its phase 2 and future studies.
Who invested in Cyteir Therapeutics
14 investors across 3 rounds
See all investors in Cyteir Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cyteir Therapeutics
Who invested in Cyteir Therapeutics?
Cyteir Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cyteir Therapeutics raised?
Cyteir Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cyteir Therapeutics last raise money?
Cyteir Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Cyteir Therapeutics do?
Based in Massachusetts, US, Cyteir Therapeutics, Inc.
Where is Cyteir Therapeutics headquartered?
Cyteir Therapeutics is headquartered in Lexington, US.
Which VCs invest in companies like Cyteir Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cyteir Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Cyteir Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.